India is setting a minimum import price for essential drug ingredients. This move aims to shield local manufacturers from cheap imports, particularly from China. The government is expanding this policy to include more raw materials. This initiative supports India's goal of becoming self-reliant in pharmaceutical production. The new rules will soon be announced.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LpjBwfM
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Import price floor on cards for critical pharma inputs






0 comments:
Post a Comment